OBJECTIVE: To test the hypothesis that different forms of neurodegeneration are differentially related to longitudinal cognitive trajectories in old age. METHODS: Participants are 420 older persons from 2 clinical-pathologic studies without cognitive impairment at study onset. They completed a battery of 17 cognitive tests annually for a minimum of 5 years, died, and underwent a neuropathologic examination to quantify neuronal neurofibrillary tangles and transactive response DNA-binding protein 43 (TDP-43) pathology and to identify Lewy bodies and hippocampal sclerosis. The authors used sigmoid mixed models based on the 4-parameter logistic distribution to decompose nonlinear global cognitive trajectories into components and assess the relation of each neuropathologic marker to each trajectory component. RESULTS: Cognitive function was assessed for a mean of 10.5 years before death. In the absence of pathology, global cognition was relatively stable before declining moderately in the last 3 to 4 years of life. Tangles were related to all trajectory components except initial level. TDP-43 pathology was the only marker related to initial level of function. It was also associated with an earlier midpoint of decline but not to slope of decline. Hippocampal sclerosis was related to an earlier midpoint of decline and more rapid slope of decline. Lewy bodies were associated with faster slope of decline and lower level of function proximate to death. CONCLUSION: Neurodegenerative processes are differentially related to cognitive trajectories, with TDP-43 pathology most potently impacting incipient cognitive decline, AD pathology and hippocampal sclerosis affecting the progression of cognitive decline, and Lewy bodies impacting terminal decline. (PsycINFO Database Record (c) 2016 APA, all rights reserved).
OBJECTIVE: To test the hypothesis that different forms of neurodegeneration are differentially related to longitudinal cognitive trajectories in old age. METHODS:Participants are 420 older persons from 2 clinical-pathologic studies without cognitive impairment at study onset. They completed a battery of 17 cognitive tests annually for a minimum of 5 years, died, and underwent a neuropathologic examination to quantify neuronal neurofibrillary tangles and transactive response DNA-binding protein 43 (TDP-43) pathology and to identify Lewy bodies and hippocampal sclerosis. The authors used sigmoid mixed models based on the 4-parameter logistic distribution to decompose nonlinear global cognitive trajectories into components and assess the relation of each neuropathologic marker to each trajectory component. RESULTS: Cognitive function was assessed for a mean of 10.5 years before death. In the absence of pathology, global cognition was relatively stable before declining moderately in the last 3 to 4 years of life. Tangles were related to all trajectory components except initial level. TDP-43 pathology was the only marker related to initial level of function. It was also associated with an earlier midpoint of decline but not to slope of decline. Hippocampal sclerosis was related to an earlier midpoint of decline and more rapid slope of decline. Lewy bodies were associated with faster slope of decline and lower level of function proximate to death. CONCLUSION: Neurodegenerative processes are differentially related to cognitive trajectories, with TDP-43 pathology most potently impacting incipient cognitive decline, AD pathology and hippocampal sclerosis affecting the progression of cognitive decline, and Lewy bodies impacting terminal decline. (PsycINFO Database Record (c) 2016 APA, all rights reserved).
Authors: Sukriti Nag; Lei Yu; Ana W Capuano; Robert S Wilson; Sue E Leurgans; David A Bennett; Julie A Schneider Journal: Ann Neurol Date: 2015-04-22 Impact factor: 10.422
Authors: Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson Journal: Ann Neurol Date: 2007-05 Impact factor: 10.422
Authors: Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett Journal: Psychol Aging Date: 2002-06
Authors: Patricia A Boyle; Jingyun Yang; Lei Yu; Sue E Leurgans; Ana W Capuano; Julie A Schneider; Robert S Wilson; David A Bennett Journal: Brain Date: 2017-03-01 Impact factor: 13.501
Authors: Shahram Oveisgharan; Lei Yu; Robert J Dawe; David A Bennett; Aron S Buchman Journal: J Gerontol A Biol Sci Med Sci Date: 2020-03-09 Impact factor: 6.053
Authors: Aron S Buchman; Lei Yu; Shahram Oveisgharan; Jose M Farfel; Julie A Schneider; David A Bennett Journal: J Gerontol A Biol Sci Med Sci Date: 2021-03-31 Impact factor: 6.053
Authors: Robert S Wilson; Kumar B Rajan; Lisa L Barnes; Willemijn Jansen; Priscilla Amofa; Jennifer Weuve; Denis A Evans Journal: Neuropsychol Dev Cogn B Aging Neuropsychol Cogn Date: 2017-03-23
Authors: Xiuming Zhang; Elizabeth C Mormino; Nanbo Sun; Reisa A Sperling; Mert R Sabuncu; B T Thomas Yeo Journal: Proc Natl Acad Sci U S A Date: 2016-10-04 Impact factor: 11.205
Authors: Willemijn J Jansen; Robert S Wilson; Pieter Jelle Visser; Sukriti Nag; Julie A Schneider; Bryan D James; Sue E Leurgans; Ana W Capuano; David A Bennett; Patricia A Boyle Journal: Neurobiol Aging Date: 2017-09-05 Impact factor: 4.673
Authors: David A Bennett; Aron S Buchman; Patricia A Boyle; Lisa L Barnes; Robert S Wilson; Julie A Schneider Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472